Hutch News

Hutch News

Stories tagged 'Good News'

3 big new leukemia research projects advance cutting-edge cell therapies, stem cell transplant

$20M renewal of 4-decade-long federal grant to Hutch scientists

May 31, 2018 | By Susan Keown / Fred Hutch News Service

The National Cancer Institute has awarded Hutch with five years and nearly $20 million in funding for research to develop better therapies for people with blood cancers. The award is the latest renewal of a grant that has been funded continuously for more than 40 years.

View story >


Fred Hutch gets funding ‘Lyft’ from rideshare company

‘Round Up & Donate’ in-app feature lets passengers donate to cancer research

May 31, 2018

Lyft, the fastest-growing U.S. rideshare company, today announced that Fred Hutchinson Cancer Research Center will be added to the list of nonprofits that benefit from an in-app feature that lets passengers round up their fare to the nearest dollar and donate the difference to their charity of choice.

View story >


Nanoparticles take immunotherapy in new direction

Hutch scientist to use nanoparticles to reprogram macrophages to tackle brain tumors

May 30, 2018 | By Sabrina Richards / Fred Hutch News Service

Dr. Fan Zhang has received funding from the American Brain Tumor Association to develop nanoparticles that can tackle a type of brain cancer called glioblastoma.

View story >


Cancer database for Washington state and national SEER registry renewed for up to 10 years

Fred Hutch’s cancer registry has been a mainstay of epidemiological research since 1974

May 24, 2018 | By Diane Mapes / Fred Hutch News Service

Fred Hutchinson Cancer Research Center’s award-winning Cancer Surveillance System database, or CSS, which folds into the larger national cancer registry, the Surveillance, Epidemiology and End Results Program, or SEER, has received a contract renewal of up to 10 years from the National Cancer Institute.

View story >


Gene editing shows promise for sickle cell and related disorders

Preclinical results offer new hope in group of dangerous inborn diseases

May 23, 2018 | By Susan Keown / Fred Hutch News Service

New research, not yet in humans, suggests that a novel gene-editing strategy holds promise for people with sickle cell disease and other serious inborn disorders of hemoglobin.

View story >


Dr. Jesse Bloom named Howard Hughes Medical Institute investigator

Biologist uses viruses to study molecular evolution

May 23, 2018 | By Sabrina Richards / Fred Hutch News Service

Dr. Jesse Bloom, a researcher in Fred Hutchinson Cancer Research Center’s Basic Sciences Division and Herbold Computational Biology Program, has been named a Howard Hughes Medical Institute Investigator.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.